InvestorsHub Logo
Followers 52
Posts 4109
Boards Moderated 0
Alias Born 07/03/2005

Re: None

Thursday, 11/11/2021 4:10:51 PM

Thursday, November 11, 2021 4:10:51 PM

Post# of 4057
Co-Diagnostics EPS beats by $0.17, beats on revenue
Nov. 11, 2021 4:02 PM ETCo-Diagnostics, Inc. (CODX)By: Gaurav Batavia, SA News Editor
Co-Diagnostics (NASDAQ:CODX): Q3 GAAP EPS of $0.38 beats by $0.17.
Revenue of $30.1M (+37.9% Y/Y) beats by $5.78M.
Press Release
Full Year 2021 Outlook:Co-Diagnostics is offering the following guidance for its full year of 2021:

Revenue to be in the range of $96.0 million to $100.0 million vs. $23.52M consensus.
Diluted earnings per share forecasted to be in the $1.07 to $1.16 range vs. $0.14 consensus, with shares outstanding expected to be approximately 30 million and a corporate effective tax rate of approximately 18.0%.

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CODX News